Abiopharma

Clinical trial NCT03389802 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-07-20

Clinical trial NCT06101342: primary completion date: 2028-01-01 → 2026-07-27.

Clinical trial NCT07560618 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-07-21

Clinical trial NCT05671510: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04943497: enrollment: 2424 → 2390 participants.

Clinical trial NCT06192563 updates: 1. enrollment: 150 → 230 participants 2. collaborators added: Regeneron Pharmaceuticals

Clinical trial NCT07712874: start date: 2026-08-17 → 2026-08-18.

Clinical trial NCT05675449 updates: 1. primary completion date: 2025-07-07 → 2026-03-11 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT02732184 updates: 1. phase: PHASE2 → PHASE1 2. start date: 2016-08-01 → 2016-08-15 3. completion date: 2017-12-01 → 2017-11-01 4. primary completion date: 2017-12-01 → 2017-11-01 5. enrollment: 29 → 21 participants 6. intervention model: SINGLE_GROUP → SEQUENTIAL 7. collaborators added: Aeglea Biotherapeutics (Study sponsor)

Clinical trial NCT06393920 updates: 1. completion date: 2027-07-01 → 2028-07-31 2. primary completion date: 2026-07-01 → 2026-10-31